Real-time enrollment status for this solid tumor, adult clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 5:58 AM UTC
| NCT Number | NCT06444815 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor, Adult |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 7 sites in the US |
| Sponsor | KaliVir Immunotherapeutics |
| Last Updated on CT.gov | April 7, 2026 (Apr 7, 2026) |
As of August 29, 2026: Clinical trial NCT06444815 is currently recruiting participants. This phase1 study for solid tumor, adult is actively seeking new participants at 7 locations across the United States. The study is sponsored by KaliVir Immunotherapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06444815 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06444815 was last updated Apr 7, 2026 (April 7, 2026). HelloStudys verifies this status automatically.